Mesoblast Limited (MESO)
(Real Time Quote from BATS)
$8.22 USD
+0.33 (4.18%)
Updated May 23, 2024 12:32 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Mesoblast Limited falls in the month of June.
All items in Millions except Per Share data.
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 71 | 60 | 137 | 129 | 50 |
Receivables | 7 | 4 | 5 | 2 | 4 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 3 | 5 | 7 | 6 | 8 |
Total Current Assets | 82 | 70 | 148 | 137 | 63 |
Net Property & Equipment | 1 | 2 | 3 | 2 | 1 |
Investments & Advances | 2 | 2 | 2 | 2 | 2 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 577 | 579 | 581 | 582 | 583 |
Deposits & Other Assets | 2 | 2 | 2 | 3 | 3 |
Total Assets | 669 | 662 | 745 | 734 | 652 |
Liabilities & Shareholders Equity | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 20 | 23 | 20 | 25 | 13 |
Current Portion Long-Term Debt | 6 | 5 | 53 | 32 | 14 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 12 | 20 | 19 | 29 | 17 |
Total Current Liabilities | 42 | 51 | 94 | 90 | 44 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 1 | 11 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 103 | 92 | 41 | 57 | 67 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 19 | 15 | 20 | 30 | 48 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 168 | 165 | 163 | 184 | 171 |
Shareholders Equity | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1,249 | 1,165 | 1,163 | 1,051 | 910 |
Capital Surplus | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | -821 | -739 | -648 | -549 | -470 |
Other Equity | 74 | 71 | 66 | 47 | 41 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 502 | 497 | 581 | 549 | 481 |
Total Liabilities & Shareholder's Equity | 669 | 662 | 745 | 734 | 652 |
Total Common Equity | 502 | 497 | 581 | 549 | 481 |
Shares Outstanding | 81.40 | 65.00 | 64.80 | 58.40 | 49.80 |
Book Value Per Share | 6.17 | 7.65 | 8.97 | 9.41 | 9.66 |
Fiscal Year End for Mesoblast Limited falls in the month of June.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,921 | -99,999 | 71 | 49 |
Receivables | NA | 4 | NA | 7 | 8 |
Notes Receivable | NA | NA | NA | 0 | 0 |
Inventories | NA | NA | NA | 0 | 0 |
Other Current Assets | NA | 4 | NA | 3 | 4 |
Total Current Assets | NA | 85 | NA | 82 | 61 |
Net Property & Equipment | NA | 1 | NA | 1 | 1 |
Investments & Advances | NA | 1 | NA | 2 | 2 |
Other Non-Current Assets | NA | NA | NA | 0 | 0 |
Deferred Charges | NA | NA | NA | 0 | 0 |
Intangibles | NA | 577 | NA | 577 | 578 |
Deposits & Other Assets | NA | 2 | NA | 2 | 2 |
Total Assets | NA | 670 | NA | 669 | 650 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | NA | 0 | 0 |
Accounts Payable | NA | 11 | NA | 20 | 21 |
Current Portion Long-Term Debt | NA | 9 | NA | 6 | 7 |
Current Portion Capital Leases | NA | NA | NA | 0 | 0 |
Accrued Expenses | NA | NA | NA | 0 | 0 |
Income Taxes Payable | NA | NA | NA | 0 | 0 |
Other Current Liabilities | NA | 9 | NA | 12 | 22 |
Total Current Liabilities | NA | 31 | NA | 42 | 54 |
Mortgages | NA | NA | NA | 0 | 0 |
Deferred Taxes/Income | NA | NA | NA | 0 | 0 |
Convertible Debt | NA | NA | NA | 0 | 0 |
Long-Term Debt | NA | 107 | NA | 103 | 99 |
Non-Current Capital Leases | NA | NA | NA | 0 | 0 |
Other Non-Current Liabilities | NA | NA | 19 | 11 | |
Minority Interest (Liabilities) | NA | NA | NA | 0 | 0 |
Total Liabilities | NA | 162 | NA | 168 | 168 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | NA | 0 | 0 |
Common Stock (Par) | NA | 1,286 | NA | 1,249 | 1,208 |
Capital Surplus | NA | NA | NA | 0 | 0 |
Retained Earnings | NA | -853 | NA | -821 | -799 |
Other Equity | NA | 76 | NA | 74 | 74 |
Treasury Stock | NA | NA | NA | 0 | 0 |
Total Shareholder's Equity | NA | 509 | NA | 502 | 482 |
Total Liabilities & Shareholder's Equity | NA | 670 | NA | 669 | 650 |
Total Common Equity | 0 | 100,508 | 0 | 502 | 482 |
Shares Outstanding | 114.00 | 101.50 | 81.40 | 81.40 | 73.70 |
Book Value Per Share | 0.00 | 990.22 | 0.00 | 6.17 | 6.54 |